Viele Hände übereinander symbolisieren unsere Arbeit im Team Header_UEber_Uns.jpg

News

2019

Direct-to-Patient Logistics and In-Home Nursing Schemes Seminar: Ute Bertelsmann und Rebeca González Vicedo as Speakers

The benefits of in-home nursing in clinical trials are numerous and they differ between stakeholder sponsors, CROs, sites and patients. But at what point do you decide to include homecare in your project?

Direct-to-Patient projects are complex and require collaboration and planning. Deliveries must often be precisely timed to coincide with the patient's availability of nurse home visits. Immediate proof that temperature control has been maintained is required prior to administering medication. Patient samples are packages for delivery to testing labs.

All of this requires the highest level of training and professionalism, discover insights on home care visits in clinical trials as we take you through the journey from destination to enrolment.

Key Learning Points:

  • Learn about new strategies to improve clinical trial enrolment and how to increase overall trial efficiency
  • Learn about World Courier's latest developments and operational set-ups in Direct-to-Patient logistics

Agenda:

  • Convenient? Compliance? Retention?: Discussing the benefits of In-Home nursing in clinical trials for patients, sites, CROs and sponsors
  • World Courier Office Tour
  • Saving one patient at a time: Practical Aspects of Direct-to-Patient clinical trials, logistical challenges and viable solutions

The event is free of charge, lunch and coffee will be served at the event. Ute Bertelsmann and Rebeca Gonzalez Vicedo of emovis GmbH and emovis Homecare Visits will be speakers at the seminar.

Sign up here

2018

March

Patient Partnering in Clinical Development

The Patient Partnering in Clinical Development is held in Berlin on March 6.

More details soon.

2017

November

Federal Association of Contract Research Organisations (BVMA e.V.): Election of new Executive Board

München, 23 November 2017. Prior to its 25th Symposium, the Federal Association of Contract Research Organisations (BVMA e.V.) in Germany announced the election of the new Executive Board. Martin Krauss was elected to serve as President. Martin Krauss is co-founder and Managing Director of FGK Clinical Research GmbH and has been a member of the Board before. Ralf Freese from CTC North GmbH & Co. KG was appointed Vice President. Also joining the Board is Dr Yvonne Rollinger, Managing Director of OmniComm Europe GmbH.

Dr Dagmar Chase, Managing Director of Clinrex GmbH, a Board member since 1993 and President since 2001, as well as Dr Michael Gierend, Managing Director of medicomp GmbH, Board member since 1997 and Vice President for 16 years, were no longer standing for re-election.

Dr Dagmar Chase about the new appointments: “The BVMA is an important stakeholder of clinical research in Germany. It was very important for us, the previous Board members, to have a smooth transition to the new executive leadership, and this can now be accomplished. A new generation will now take over leadership, but will still be supported by previous Board members who continue their membership in the association. The new Board with Martin Krauss as President is well-positioned and well-prepared to continue the Association’s successful work.”

The new Board is looking forward to take on its duties and new challenges”, the new President Martin Krauss commented on his appointment. “Clinical research faces constant changes - digitalization is just one example - and new developments come up more and more frequently. A close cooperation and exchange of information between members, representatives from industry, regulatory bodies, ethics committees, and other stakeholders are essential to keep up with these growing demands. The BMVA will also focus in the future on keeping Germany attractive for clinical research and strengthening clinical research for the patient’s benefit. I would like to express gratitude to Dagmar Chase, who has been the BVMA’s president for many years, and has made the BVMA an important stakeholder.”

About BVMA:

The BVMA was founded in July 1991 as a representative body for CROs (Contract Research Organisations) based in German-speaking countries. The current 41 members are service providers in research and development of pharmaceuticals and medical devices. Throughout Germany, the BVMA represents about 4000 employees in clinical research. In the past years, the association has successfully strived to be represented in relevant regulatory bodies. As a co-founder and member of the European umbrella organisation (European CRO Federation, EUCROF), the BVMA also ensures its international position. The current President of the EUCROF, Dr Martine Dehlinger-Kremer, is a BVMA member. The BVMA is based in München, Germany.

BVMA symposium:

Every year in November, the BVMA organises a symposium, which became (with more than 300 participants) one of the most important conferences in clinical research. At the same time, the symposium has served for the last 25 years as an established platform for the exchange of information between stakeholders in this field.

http://www.bvma.de/en/executive-board/

Dr. med. Bettina Bergtholdt as a panelist at the Next Generation Nicotine Delivery Conference - London (UK)

emovis will not only attend the professional congress"Next Generation Nicotine Delivery Conference 2017" on Nov. 14 -15, you may encounter the Managing Director emovis-,Dr. Bettina Bergtholdt as a panelist. Together with Dr. Alexander (Sascha) Nussbaum from Philip Morris she will share her expertise in the subject "The role of clinical trials in driving the success of new nicotine products".

Dr. med. Bettina Bergtholdt as a panelist at the PCT 2017: Partnerships in Clinical Trials Europe – Amsterdam (NL)

This year’s PCT Europe is held in Amsterdam from Nov. 28 – 29. emovis will be in attendance and Dr. Bettina Bergtholdt can be experienced within the framework of the congress multiple times with her expertise. 1st as a panelist on the panel "Recruitment from the perspective of an investigative Site – pitfalls and strategies" as well as in a workshop on Nov 27, addressing the topic "Briefing Day A: The Outsourcing and Partnering Forum".